Browsing Category
CDMO and CMO
PMC Isochem – Your partner for Smart & Innovative Solutions
See in the following a part of the company brochure by PMC Isochem
PMC Isochem offers Drug Delivery solutions, CDMO services and Active Pharmaceutical Ingredients and intermediates:
From development to GMP production of Amphiphilic and hydrophilic polymers for pharmaceutical…
Read More...
Read More...
isodel PAA – PMC Isochem as CDMO for PolyAmino Acids
See in the following the overview on the usage fields of polyamino acids and the service spectrum of PMC Isochem as CDMO in this area:
Why PolyAmino Acids - PAA
Functional Excipients
Biodegradable Polymers
Drug Delivery & Drug Conjugate
Alternative to PEG (i.e. polysarcosine)…
Read More...
Read More...
Outlining Successful Steps for Scale-Up and BLA Filings
In the high-stakes world of microbial biomanufacturing, there are dozens of critical moments and crucial decisions to be made on the path from clinical trials to regulatory approval to commercial manufacturing. Planning and executing both scale-up and a successful biologic licensing application…
Read More...
Read More...
Formulating for the Future: Oral Drug Delivery for Improving Bioavailability & Patient Outcomes
Oral drug administration is critical for the delivery of drugs in various therapeutic areas, such as cardiovascular and pain management. It is considered the preferred route of administration due to its significant advantages, including being both painless and convenient. The importance of oral drug…
Read More...
Read More...
Evonik – Now also a global CDMO for lipid nanoparticles
INTEGRATED CDMO SERVICES FOR LIPID-NANOPARTICLE-BASED GENETIC DRUGS AND OTHER NANOMEDICINES SINCE THE 1990S
Evonik Vancouver Laboratories, formerly known as Transferra Nanosciences Inc. or Northern Lipids, has been a market CDMO leader for lipid nanoparticle (LNP)-/liposome-based formulations for…
Read More...
Read More...
Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA
Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash.
Targeted acquisition to accelerate novel modalities service offering
Exelead, a full-service CDMO, focusing…
Read More...
Read More...
Solving Bioavailability Challenges Using A Molecule’s Target Product Profile (TPP)
What is the Target Product Profile (TPP)?
The Target Product Profile (TPP) describes the desired characteristics of the proposed drug product aimed at a particular disease. We consider the TPP to be a living document that may change as together we learn more about your molecule. The TPP will…
Read More...
Read More...
European CDMOs capability mapping – Small Molecules and Biologics
Fuliginous Management Ltd is a service providing company to the Contract Manufacturing Market, supporting both CMOs and Pharma Companies cooperating with CMOs. Get prepared for 2021 and acquire the updated CDMOs capibility mapping.
Fuliginous Management Consulting offers services to the…
Read More...
Read More...